v3.23.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES    
Net income (loss) from continuing operations $ (5,429,521) $ 666,293
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 23,131 13,886
Amortization of loan discount 253,823 1,051,264
Other income (150,256) 0
Goodwill impairment 2,092,048 0
Loss on finance penalties and fees 2,063,916 0
Gain on refinance of debt (1,397,271) 0
Gain on forgiveness of debt 0 (739,450)
(Increase) decrease in:    
Accounts receivable (598,381) (2,157,880)
Right of use - assets 64,696 100,715
Prepaids and other current assets 8,059 (30,282)
Land 0 63,000
Increase(decrease) in:    
Accounts payable and accrued expense 750,878 188,038
Due to from related party 36,988 (42,827)
Accrued officers compensation 873,506 764,835
Accrued interest 379,428 (265,860)
Right of use - liabilities (71,371) (108,043)
Deferred revenue 0 (353,830)
Net cash used in operating activities (1,100,327) (850,141)
Net cash used in Discontinued Operations – Operating (42,633) (201,208)
INVESTING ACTIVITIES    
Purchase of property and equipment 0 (3,407)
Acquisition of Nova Ortho and Spine PLLC, net of cash acquired 0 (2,320,235)
Net cash (used in) investing activities 0 (2,323,642)
FINANCING ACTIVITIES    
Repayments to directors and officers (3,573) 0
Proceeds from convertible notes payable 879,083 444,500
Proceeds from PPP loan and SBA loans (3,068) 547,050
Repayment of credit line 0 (51,927)
Repayment to convertible notes payable (5,908) (30,777)
Payment of notes payable - 3rd party 0 (28,318)
Dividend on preferred stock (102,740) (203,880)
Issuance of preferred stock 25,000 3,000,000
Net cash provided by financing activities 788,794 3,676,648
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS (354,166) 301,657
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR 580,968 279,311
CASH AND CASH EQUIVALENTS, END OF YEAR 226,802 580,968
SUPPLEMENTARY DISCLOSURE OF CASH FLOW INFORMATION    
Cash paid during the year for Interest 0 127,242
NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Common stock issued upon conversion of notes payable 0 885,691
Common stock issued for settlement of accrued expense 0 388,143
Preferred stock issued for business acquisition 3,275,000 3,579,336
Preferred stock issued upon conversion of notes payable and accrued interest 0 563,196
Preferred stock issued upon exchange of defaulted convertible notes payable 1,500,000 0
Derivative liability settled upon conversion $ 0 $ 1,396,610